Drug development: successes, problems and pitfalls-the industry perspective

被引:5
|
作者
Wein, Wolfgang [1 ]
机构
[1] Wein Merck KGaA, Vienna, Austria
关键词
D O I
10.1136/esmoopen-2016-000033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Models and approaches to early neuropharmacologic drug development: An industry perspective
    Tallman, J
    BIOLOGICAL PSYCHIATRY, 1998, 43 : 82S - 82S
  • [22] Recombinant Drug Development, Regulation, and Commercialization An Indian Industry Perspective
    Sahoo, Niharika
    Manchikanti, Padmavati
    BIODRUGS, 2011, 25 (02) : 105 - 113
  • [23] Recombinant Drug Development, Regulation, and CommercializationAn Indian Industry Perspective
    Niharika Sahoo
    Padmavati Manchikanti
    BioDrugs, 2011, 25 : 105 - 113
  • [24] Role of population pharmacokinetics in drug development - A pharmaceutical industry perspective
    Samara, E
    Granneman, R
    CLINICAL PHARMACOKINETICS, 1997, 32 (04) : 294 - 312
  • [25] An industry perspective on tiered approach to the investigation of metabolites in drug development
    Huskey, Su-Er W.
    Li, Wenkui
    Mangold, James B.
    Flarakos, Jimmy
    BIOANALYSIS, 2014, 6 (05) : 617 - 628
  • [26] SOME PROBLEMS AND SUCCESSES IN CONTROLLING NOISE EXPOSURE IN CALIFORNIA INDUSTRY
    STEFFAN, WW
    JOURNAL OF THE AUDIO ENGINEERING SOCIETY, 1970, 18 (03): : 330 - &
  • [27] Industry Perspective - What does Industry Need to Accelerate Drug Product and Process Development?
    Chatterjee, Bikash
    Steiner, Richard
    Kaul, Goldi
    PHARMACEUTICAL RESEARCH, 2024, 41 (01) : 7 - 11
  • [28] Industry Perspective – What does Industry Need to Accelerate Drug Product and Process Development?
    Bikash Chatterjee
    Richard Steiner
    Goldi Kaul
    Pharmaceutical Research, 2024, 41 : 7 - 11
  • [30] The Changing Paradigm of Drug-Resistant Tuberculosis Treatment: Successes, Pitfalls, and Future Perspectives
    Dookie, Navisha
    Ngema, Senamile L.
    Perumal, Rubeshan
    Naicker, Nikita
    Padayatchi, Nesri
    Naidoo, Kogieleum
    CLINICAL MICROBIOLOGY REVIEWS, 2022, 35 (04)